BCI
IBBQ icon

Brinker Capital Investments’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Brinker Capital Investments’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Sell
13,753
-48
-0.3% -$1.4K ﹤0.01% 1545
2025
Q4 		$392K Buy
+13,801
New +$376K ﹤0.01% 1692

Other funds holding IBBQ

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Brinker Capital Investments's IBBQ Position: Q1 2026 in Review

Brinker Capital Investments reduced its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 0.35% in Q1 2026, selling an estimated $1.4K and leaving 13,753 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Brinker Capital Investments first reported a position in IBBQ in Q4 2025 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Brinker Capital Investments held 13,753 shares of Invesco NASDAQ Biotechnology ETF worth $399K as of Q1 2026.
  • Brinker Capital Investments sold 48 Invesco NASDAQ Biotechnology ETF shares in Q1 2026, an estimated $1.4K.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #1545 holding.
  • Brinker Capital Investments first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2025 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.